Padagis Israel

Padagis-Israel is a leading pharmaceutical company. We are dedicated to taking care of our consumers and patients and to offering a wide variety of Rx, biosimilars, non-prescription drugs, generic drugs, glucose meters, medical equipment and consumer products. Our customers include hospitals, health funds and pharmacies in the institutional markets, private markets and pharmacy chains. The company has been active in Israel since 1961, founded as "Agis" company. In 2005, Agis was purchased by Perrigo (Perrigo Company PLC) the large OTC pharmaceutical company from the US. In 2021 the Rx Pharmaceuticals Business, now known as Padagis LLC company, was sold to the Altaris fund, whose main business is a venture capital fund for the medical field. Padagis currently employs around 850 employees in Israel and is one of the largest employers in the Negev area. More than 600 of our employees are employed in the development and production factory located in Yeruham, and the rest are employed in the commercial and logistics facility located in the Shoham Industrial Park area. פאדאגיס-ישראל הינה חברה מובילה בתחום הפרמצבטיקה ושיווק תרופות. חרטנו על דיגלנו לדאוג לקהל הצרכנים והמטופלים שלנו ולהציע מגוון רחב של תרופות מרשם, תרופות ביו-סימילריות, תרופות ללא מרשם, תרופות גנריות, מדי סוכר רציפים, ציוד רפואי ומוצרי צריכה. על לקוחותינו נמנים כלל בתי החולים, קופות החולים, בתי המרקחת ורשתות הפארם. החברה פעילה בישראל עוד משנת 1961 עת הוקמה כ"אגיס". בשנת 2005 נרכשה אגיס על ידי חברת פריגו ענקית התרופות ללא מרשם מארה"ב. בשנת 2021 נמכרה פעילות תרופות המרשם, שפאדאגיס ישראל חלק ממנה, לקרן אלטריס שעיקר עיסוקה קרן הון סיכון לתחום הרפואי. פאדאגיס מעסיקה כיום כ- 850 עובדים.ות בישראל ונמנית על המעסיקות הגדולות בנגב. למעלה מ- 600 מעובדינו מועסקים במפעל לפיתוח וייצור תרופות גנריות בירוחם, בעוד המרכז המסחרי והלוגיסטי ממוקם בפארק התעשייה בשוהם.

Neopharm Group

Neopharm Group is engaged in research and development, manufacturing, marketing, sales and distribution of a broad range of products in the health care field in 60 countries globally. Founded in 1941, over 900 employees worldwide, offices in Israel, Europe, U.S. and the Middle East and annual revenues exceeding $US400 million. We operate in three main areas: pharmaceuticals, consumer products and medical device. Group companies, among others: "Neopharm Israel" provides innovative solutions for improving health in the fields of oncology, hematology, autoimmune and metabolic diseases, neurology, gastroenterology and dermatology. Also Imports drugs that are unregistered in Israel with a permit of the Ministry of Health. Provides medical care to patients in their own home as an alternative to hospitalization. "Neovi" Swiss-based global biopharmaceutical company developing and bringing to market novel antibody therapies in transplantation medicine, oncology and immune disorders. "Eldan" provides medical, analytical and scientific instruments and equipment as well as advanced materials and technologies in the areas of healthcare and life science. "Neopharm consumer products" offers wellness and healthcare products via our in-house development and via partnering with world's leading Consumer Healthcare companies. Operates in the areas of nutrition, wet-wipes, diapers, skin care and over the counter medicines. "Promedico" provides logistics and supply chain management services. "Neopharm Cure" specializes in the preparation and delivery of medicinal treatments, given by infusion, customized for patients in hospitals, in the community or at home. "DPL" specializes in the production, marketing and export of advanced absorbent products such as: disposable diapers, wipes and sanitary napkins. To work at Neopharm is to be part of a large group that operates with humanity, professionalism and innovation. For all Jobs: https://www.neopharmgroup.com/careers/new/public

PharmaCare Laboratories

PharmaCare is one of the largest Australian-owned health, wellness and consumer goods companies in the country. An Australian-born and built success story, PharmaCare is dedicated to enriching people’s lives through improved health and wellness. Despite its products being available globally, its soul is Australian, its quality is Australian, and its spirit of honesty, hard work and entrepreneurial drive is Australian. PharmaCare’s trusted, household brands include Sambucol, Nature’s Way, Bioglan, Medi+, Ease-a-Cold, Skin Doctors, KP24, Brut, Norsca, Bounce and many more. Our global wheelhouse of brands is available in 40 countries, over 5,200 pharmacies, 3,000 supermarkets, plus department and variety stores all over Australia, New Zealand, Asia, The America's and Europe.

MMS

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating. For more information, visit www.mmsholdings.com

Advarra

Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.